| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Everolimus | FAERS: 4 | US FAERS | |
| 2 | Diclofenac | FAERS: 2 | US FAERS | |
| 3 | Arthrotec | FAERS: 1 | US FAERS | |
| 4 | Cinacalcet | FAERS: 1 | US FAERS | |
| 5 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 6 | NuvaRing | FAERS: 1 | US FAERS | |
| 7 | Terbinafine | FAERS: 1 | US FAERS | |
| 8 | Thyroxine | FAERS: 1 | US FAERS | |
| 9 | Warfarin | FAERS: 1 | US FAERS | |
| 10 | Amisulpride | OFFSIDES | ||
| 11 | Clozapine | Canada Vigilance: 1 | Canada Vigilance OFFSIDES | |
| 12 | Deferasirox | OFFSIDES | ||
| 13 | Prazepam | OFFSIDES | ||
| 14 | dipropylacetamide | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.